End in sight for Avecho as Phase III CBD trial moves into final stage by Adam Sheldon August 31, 2026August 31, 2026 Avecho Biotechnology has restarted recruitment for the final stage of its pivotal Phase III insomnia trial […]
Avecho recruits biotech exec to drive CBD global licensing push by Adam Sheldon August 24, 2026August 27, 2026
Wait for CBD analysis was ‘torture’, says Avecho CEO as talks resume over licencing deals by Steve Jones July 9, 2026July 9, 2026
News in brief: Cannaponics raise tops $2.5m; Avecho receives $1.98m R&D incentive; Elixinol backs capital raising plans by Adam Sheldon May 27, 2026June 8, 2026
‘June will be huge’: Avecho boss bullish ahead of CBD trial analysis by Steve Jones March 26, 2026March 26, 2026
Avecho prepares for potentially ‘transformative’ CBD trial results by Adam Sheldon March 4, 2026June 8, 2026
News in brief: Avecho gains key patent allowances; Montu expands medical affairs team by Adam Sheldon December 9, 2025February 21, 2026
Avecho vision takes shape as CEO flags ‘monster’ OTC opportunity by Steve Jones March 11, 2025April 29, 2026
Does CBN hold the key to better sleep? Lambert Initiative delves into ‘cannabis folklore’ – with promising results by Steve Jones November 12, 2024November 14, 2024
Second trial flagged by Ecofibre in bid to get S3 product over the line by Steve Jones February 1, 2023February 1, 2023
